Answers are grounded in this paper and cite their sources.
There are several basophil activation and degranulation markers for basophil activation test discovered in recent years. However, only CD63 and CD203c are actively used. The activation and degranulation markers (CD11b, CD13, CD63, CD69, CD107a, CD164, CD203c and CD300a) were characterized from the point of view of the possibility to use for BAT and their clinical efficiency. It has been shown that the degranulation marker CD107a and the activation marker CD11b have high sensitivity and specificity and can be used to diagnose hypersensitivity to pollen allergens.
No takes yet. Share an insight, caveat, or question.
Ramanava et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: